Raymond James Financial Inc Cognition Therapeutics Inc Transaction History
Raymond James Financial Inc
- $258 Billion
- Q1 2025
A detailed history of Raymond James Financial Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Raymond James Financial Inc holds 21,000 shares of CGTX stock, worth $6,510. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,000
Previous 17,500
20.0%
Holding current value
$6,510
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
14MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.86 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$683,6660.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$384,1410.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.01MShares$312,3510.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$188,6000.01% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $7.04M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...